Hallmarks of aromatase inhibitor drug resistance revealed by epigenetic profiling in breast cancer.
Jansen MP, Knijnenburg T, Reijm EA, Simon I, Kerkhoven R, Droog M, Velds A, van Laere S, Dirix L, Alexi X, Foekens JA, Wessels L, Linn SC, Berns EM, Zwart W.
Jansen MP, et al. Among authors: wessels l.
Cancer Res. 2013 Nov 15;73(22):6632-41. doi: 10.1158/0008-5472.CAN-13-0704.
Cancer Res. 2013.
PMID: 24242068